-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TegKlMlmdj1o+hgHHHX6owjePOJKcn7yO0apkPEjJYWldZDKnbnVeWUftJmfJoso xo9GHNf0PoaPWvXgfzHslw== 0001045969-01-000190.txt : 20010223 0001045969-01-000190.hdr.sgml : 20010223 ACCESSION NUMBER: 0001045969-01-000190 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010214 GROUP MEMBERS: COLUMBINE VENTURE FUND II LP /DE/ GROUP MEMBERS: COLUMBINE VENTURE MANANGEMENT II GROUP MEMBERS: SHERMAN J. MULLER GROUP MEMBERS: TERENCE E. WINTERS SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: COLLAGENEX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001012270 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521758016 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-47825 FILM NUMBER: 1541549 BUSINESS ADDRESS: STREET 1: 41 UNIVERSITY DRIVE CITY: NEWTON STATE: PA ZIP: 18940 BUSINESS PHONE: 2155797388 MAIL ADDRESS: STREET 1: 41 UNIVERSITY DRIVE CITY: NEWTON STATE: PA ZIP: 18940 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: COLUMBINE VENTURE FUND II LP /DE/ CENTRAL INDEX KEY: 0001055611 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 841090581 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 5460 S QUEBEC ST STREET 2: STE 270 CITY: ENGLEWOOD STATE: CO ZIP: 80111 BUSINESS PHONE: 3035928344 MAIL ADDRESS: STREET 1: 5460 S QUEBEC ST STREET 2: STE 270 CITY: ENGLEWOOD STATE: CO ZIP: 80111 SC 13G/A 1 0001.txt SCHEDULE 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* COLLAGENEX PHARMACEUTICALS, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 19419B-10-0 (CUSIP Number) December 31, 2000 (Annual Filing) (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [_] Rule 13d-1(c) [X] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP NO. 19419B-10-0 13G Page 2 of 8 ----------- --- --- - ------------------------------------------------------------------------------ NAMES OF REPORTING PERSONS. 1 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). Columbine Venture Fund II, L.P. - ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) 2 (a) [_] (b) [_] - ------------------------------------------------------------------------------ SEC USE ONLY 3 - ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 4 Delaware, USA - ------------------------------------------------------------------------------ SOLE VOTING POWER 5 NUMBER OF 654,082 SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 6 OWNED BY ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 7 REPORTING 654,082 PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH 8 - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 654,082 - ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 10 (SEE INSTRUCTIONS) - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 11 7.5% - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) 12 PN - ------------------------------------------------------------------------------ CUSIP NO. 19419B-10-0 13G Page 3 of 8 ----------- --- --- - ------------------------------------------------------------------------------ NAMES OF REPORTING PERSONS. 1 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). Columbine Venture Management II - ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) 2 (a) [_] (b) [_] - ------------------------------------------------------------------------------ SEC USE ONLY 3 - ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 4 Delaware, USA - ------------------------------------------------------------------------------ SOLE VOTING POWER 5 NUMBER OF 713,446 SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 6 OWNED BY ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 7 REPORTING 713,446 PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH 8 - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 713,446 - ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 10 (SEE INSTRUCTIONS) - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 11 8.1% - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) 12 PN - ------------------------------------------------------------------------------ CUSIP NO. 19419B-10-0 13G Page 4 of 8 ----------- --- --- - ------------------------------------------------------------------------------ NAMES OF REPORTING PERSONS. 1 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). Sherman J. Muller - ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) 2 (a) [_] (b) [_] - ------------------------------------------------------------------------------ SEC USE ONLY 3 - ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 4 USA - ------------------------------------------------------------------------------ SOLE VOTING POWER 5 NUMBER OF SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 6 OWNED BY 713,446 ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 7 REPORTING PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH 8 713,446 - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 713,446 - ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 10 (SEE INSTRUCTIONS) - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 11 8.1% - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) 12 IN - ------------------------------------------------------------------------------ CUSIP NO. 19419B-10-0 13G Page 5 of 8 ----------- --- --- - ------------------------------------------------------------------------------ NAMES OF REPORTING PERSONS. 1 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). Terence E. Winters - ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) 2 (a) [_] (b) [_] - ------------------------------------------------------------------------------ SEC USE ONLY 3 - ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 4 USA - ------------------------------------------------------------------------------ SOLE VOTING POWER 5 NUMBER OF SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 6 OWNED BY 713,446 ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 7 REPORTING PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH 8 713,446 - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 713,446 - ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 10 (SEE INSTRUCTIONS) - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 11 8.1% - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) 12 IN - ------------------------------------------------------------------------------ CUSIP NO. 19419B-10-0 Page 6 of 8 ----------- --- --- Item 1 (a) Name of Issuer Collagenex Pharmaceuticals, Inc. (b) Address of Issuer's Principal Executive Offices 41 University Drive Newton, Pennsylvania 18940 Item 2 (a) Name of Person Filing Columbine Venture Fund II, L.P. (b) Address of Principal Business Office or, if none, Residence 7000 E. Belleview Avenue, Suite 150 Englewood, Colorado 80111 (c) Citizenship Delaware, USA (d) Title of Class of Securities Common Stock (e) CUSIP Number 19419B-10-0 (a) Name of Person Filing Columbine Venture Management II (b) Address of Principal Business Office or, if none, Residence 7000 E. Belleview Avenue, Suite 150 Englewood, Colorado 80111 (c) Citizenship Delaware, USA (d) Title of Class of Securities Common Stock (e) CUSIP Number 19419B-10-0 (a) Name of Person Filing Sherman J. Muller (b) Address of Principal Business Office or, if none, Residence 7000 E. Belleview Avenue, Suite 150 Englewood, Colorado 80111 (c) Citizenship USA (d) Title of Class of Securities Common Stock (e) CUSIP Number 19419B-10-0 (a) Name of Person Filing Terence E. Winters (b) Address of Principal Business Office or, if none, Residence 10040 East Happy Valley Road, No. 366 Scottsdale, Arizona 85255 (c) Citizenship USA (d) Title of Class of Securities Common Stock (e) CUSIP Number 19419B-10-0 CUSIP NO. 19419B-10-0 Page 7 of 8 ------------- --- --- Item 3. Not applicable. Item 4. Ownership. Reporting Persons incorporate by reference the information on ownership contained under numbers 5, 6, 7, 8, 9, 10 and 11 of the cover sheets. The numbers include 693,446 shares of Common Stock and options to purchase 20,000 shares of Common Stock that are now exercisable. Title to 634,082 shares of Common Stock is held by Columbine Venture Fund II, L.P. ("Columbine") which does not hold an interest in 59,364 shares of Common Stock, title to which is held by Columbine Venture Management II ("Management"). Management is the sole general partner of Columbine and is a reporting person with respect to the shares held by Columbine by virtue of its voting power and dispositive power over the shares held by Columbine. The individuals are general partners in Columbine Venture Management II, and each is a reporting person with respect to the shares held by Columbine and Management by virtue of his shared voting and dispositive power over the shares held by Columbine in which he is a general partner of the general partner and Management in which he is a general partner. Each reporting person, other than Columbine, disclaims his or its interest in the Common Stock, except to the extent of his or its proportionate interest as a partner. The reporting persons also have an interest in options exercisable for an additional 5,000 shares of Common Stock, which are not exercisable within 60 days. Item No. 5. Not Applicable. Item No. 6. No person, other than the reporting person, has a right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities. CUSIP NO. 19419B-10-0 Page 8 of 8 --- --- Item 7. Not applicable. Item 8. Not applicable. Item 9. Not applicable. Item 10. Not applicable. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 13, 2001 ---------------------------------- Date /s/ JAMES A. JACOBSON ---------------------------------- Signature James A. Jacobson, as agent and attorney-in-fact for each reporting person pursuant to powers of attorney attached hereto ---------------------------------- Name/Title -----END PRIVACY-ENHANCED MESSAGE-----